Drugs / Rat HER2 DNA
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00393783 | May 2006 → May 2027 expected | breast cancer | Memorial Sloan Kettering Cancer Center | Active not recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Rat HER2 DNA | “Rat HER2 DNA will be delivered intramuscularly at four different dose levels (0.5mg, 1mg, 3mg, or 6mg) during weeks 1, 4, 7, 10 and 13 for five injections.” NCT00393783 ↗ |
| Modality | Vaccine | “Xenogeneic HER2/Neu DNA Immunization” NCT00393783 ↗ |
| Route | Intramuscular | “Rat HER2 DNA will be delivered intramuscularly” NCT00393783 ↗ |